These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 8856043)
1. Remodeling of HDL containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: its effect on the structure and cellular cholesterol-reducing capacity of LpA-I. Ohta T; Ikeda Y; Hattori S; Matsuda I Biochim Biophys Acta; 1996 Sep; 1303(2):137-44. PubMed ID: 8856043 [TBL] [Abstract][Full Text] [Related]
2. Different effects of subclasses of HDL containing apoA-I but not apoA-II (LpA-I) on cholesterol esterification in plasma and net cholesterol efflux from foam cells. Ohta T; Saku K; Takata K; Nakamura R; Ikeda Y; Matsuda I Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):956-62. PubMed ID: 7600128 [TBL] [Abstract][Full Text] [Related]
3. LDL inhibits the mediation of cholesterol efflux from macrophage foam cells by apoA-I-containing lipoproteins. A putative mechanism for foam cell formation. Nakamura R; Ohta T; Ikeda Y; Matsuda I Arterioscler Thromb; 1993 Sep; 13(9):1307-16. PubMed ID: 8364015 [TBL] [Abstract][Full Text] [Related]
4. Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin: cholesterol acyltransferase. Ohta T; Nakamura R; Ikeda Y; Shinohara M; Miyazaki A; Horiuchi S; Matsuda I Biochim Biophys Acta; 1992 Nov; 1165(1):119-28. PubMed ID: 1420341 [TBL] [Abstract][Full Text] [Related]
6. High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency. Tani M; Horvath KV; Lamarche B; Couture P; Burnett JR; Schaefer EJ; Asztalos BF Atherosclerosis; 2016 Oct; 253():7-14. PubMed ID: 27573733 [TBL] [Abstract][Full Text] [Related]
7. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins. Tan KC; Shiu SW; Pang RW; Kung AW Clin Endocrinol (Oxf); 1998 Feb; 48(2):187-94. PubMed ID: 9579231 [TBL] [Abstract][Full Text] [Related]
8. Formation of new HDL particles from lipid-free apolipoprotein A-I. Clay MA; Barter PJ J Lipid Res; 1996 Aug; 37(8):1722-32. PubMed ID: 8864956 [TBL] [Abstract][Full Text] [Related]
9. Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. Forte TM; Bielicki JK; Goth-Goldstein R; Selmek J; McCall MR J Lipid Res; 1995 Jan; 36(1):148-57. PubMed ID: 7706940 [TBL] [Abstract][Full Text] [Related]
10. Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II. Clay MA; Cehic DA; Pyle DH; Rye KA; Barter PJ Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):445-51. PubMed ID: 9895287 [TBL] [Abstract][Full Text] [Related]
11. High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin: cholesterol acyltransferase. Mowri HO; Patsch JR; Ritsch A; Föger B; Brown S; Patsch W J Lipid Res; 1994 Feb; 35(2):291-300. PubMed ID: 8169533 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells. Bielicki JK; McCall MR; Forte TM J Lipid Res; 1999 Jan; 40(1):85-92. PubMed ID: 9869653 [TBL] [Abstract][Full Text] [Related]
14. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice. Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603 [TBL] [Abstract][Full Text] [Related]
15. Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase. Clay MA; Pyle DH; Rye KA; Barter PJ J Biol Chem; 2000 Mar; 275(12):9019-25. PubMed ID: 10722751 [TBL] [Abstract][Full Text] [Related]
16. In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions. Hedrick CC; Castellani LW; Wong H; Lusis AJ J Lipid Res; 2001 Apr; 42(4):563-70. PubMed ID: 11290828 [TBL] [Abstract][Full Text] [Related]
18. A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma. Miccoli R; Zhu Y; Daum U; Wessling J; Huang Y; Navalesi R; Assmann G; von Eckardstein A J Lipid Res; 1997 Jun; 38(6):1242-53. PubMed ID: 9215551 [TBL] [Abstract][Full Text] [Related]
19. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux. Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569 [TBL] [Abstract][Full Text] [Related]
20. The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol efflux. Bernini F; Calabresi L; Bonfadini G; Franceschini G Biochim Biophys Acta; 1996 Jan; 1299(1):103-9. PubMed ID: 8555242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]